- Home
- CODX vs LUMO Comparison
CODX vs LUMO Comparison
Compare CODX & LUMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CODX
- LUMO
- Stock Information
- Founded
- CODX 2013
- LUMO 2011
- Country
- CODX United States
- LUMO United States
- Employees
- CODX N/A
- LUMO N/A
- Industry
- CODX Medical/Dental Instruments
- LUMO Biotechnology: Pharmaceutical Preparations
- Sector
- CODX Health Care
- LUMO Health Care
- Exchange
- CODX Nasdaq
- LUMO Nasdaq
- Market Cap
- CODX 39.3M
- LUMO 37.7M
- IPO Year
- CODX 2017
- LUMO N/A
- Fundamental
- Price
- CODX $1.06
- LUMO $4.33
- Analyst Decision
- CODX Hold
- LUMO Buy
- Analyst Count
- CODX 1
- LUMO 4
- Target Price
- CODX $1.50
- LUMO $9.38
- AVG Volume (30 Days)
- CODX 90.9K
- LUMO 95.1K
- Earning Date
- CODX 11-07-2024
- LUMO 11-07-2024
- Dividend Yield
- CODX N/A
- LUMO N/A
- EPS Growth
- CODX N/A
- LUMO N/A
- EPS
- CODX N/A
- LUMO N/A
- Revenue
- CODX $7,321,012.00
- LUMO $2,205,000.00
- Revenue This Year
- CODX N/A
- LUMO $184.11
- Revenue Next Year
- CODX N/A
- LUMO N/A
- P/E Ratio
- CODX N/A
- LUMO N/A
- Revenue Growth
- CODX 57.16
- LUMO 26.94
- 52 Week Low
- CODX $1.00
- LUMO $1.37
- 52 Week High
- CODX $2.23
- LUMO $4.58
- Technical
- Relative Strength Index (RSI)
- CODX 34.55
- LUMO 56.37
- Support Level
- CODX $1.02
- LUMO $4.30
- Resistance Level
- CODX $1.09
- LUMO $4.39
- Average True Range (ATR)
- CODX 0.05
- LUMO 0.08
- MACD
- CODX -0.01
- LUMO -0.03
- Stochastic Oscillator
- CODX 21.74
- LUMO 36.36
About CODX Co-Diagnostics Inc.
Co-Diagnostics Inc is a molecular diagnostics company. It develops, licenses, and commercializes molecular technologies such as lab systems (MDx device) and manufacture and sell reagents used for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). CDI's low-cost system uses its tests to diagnose tuberculosis, Zika, hepatitis B and C, Malaria, dengue and HIV.The Company's technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious diseases.
About LUMO Lumos Pharma Inc.
Lumos Pharma Inc is a biopharmaceutical company that develops treatments for cancer and rare diseases. It carries out both clinical-stage and preclinical research on a range of molecules that help the immune system fight off cancer cells. The treatments are available orally and can be used in conjunction with other cancer therapies. The company also researches an Ebola vaccine. Lumos contracts with manufacturing organizations to make their treatments, engages in partnerships with pharmaceutical companies, and operates in the United States.